Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
A California company is using AI to help diagnose homeless Californians. The technology promises better access to health care, but it also raises questions.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果